Fresenius | FRE - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Akzo Nobel EUR 4.85B 0 2026-09
Alcon AG USD 21.6B 538M 2026-06
AstraZeneca USD 51.73B 1.43B 2026-09
BASF EUR 37.73B 1.41B 2026-09
Bayer EUR 29.18B 533M 2026-09
Beiersdorf EUR 9.01B 408M 2026-06
DaVita Healthcare Partners USD -591.09M 174.01M 2026-09
Demant DKK 11.24B 1.4B 2026-06
E.ON EUR 21.22B 7.6B 2026-06
Essilor EUR 39.22B 329M 2026-06
Fresenius EUR 20.51B 810M 2026-09
Fresenius Medical Care EUR 13.53B 673.44M 2026-06
Getinge SEK 30.94B 2.06B 2026-06
Givaudan CHF 4.54B 430M 2025-12
GlaxoSmithKline GBP 18.75B 1.11B 2026-09
GN Store Nord DKK 10.27B 146M 2026-06
GRIFOLS EUR 5.79B 2.19B 2026-09
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Lonza CHF 9.13B 513M 2025-12
Merck EUR 30.17B 430M 2026-06
Novartis USD 37.23B 4.72B 2026-09
Philips EUR 11.48B 84M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
RWE EUR 39.62B 3.2B 2026-06
Sanofi EUR 72.88B 3.31B 2026-09
Smith & Nephew USD 5.18B 356M 2026-06